Combined immunochemotherapy with rituximab improves overall survival in patients with follicular and mantle cell lymphoma: Updated meta-analysis results.

被引：3
|
作者：
Schulz, Holger
Bohlius, Julia
Skoetz, Nicole
Trelle, Sven
Reiser, Marcel
Kober, Thilo
Schwarzer, Guido
Herold, Michael
Dreyling, Martin
Engert, Andreas
机构：
[1] Univ Cologne, Cochrane Hematol Malignancies Grp, D-8000 Cologne, Germany
[2] Univ Freiburg, Inst Med Biometry & Med Informat, Freiburg, Germany
[3] Helios Klin Erfurt, Med Klin, Erfurt, Germany
[4] Univ Munich, Klinikum Grosshadern, Munich, Germany
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2760.2760
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2760
引用
收藏
页码：781A / 781A
页数：1
相关论文
共 50 条
  • [1] Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: A systematic review and meta-analysis
    Schulz, Holger
    Bohlius, Julia F.
    Trelle, Sven
    Skoetz, Nicole
    Reiser, Marcel
    Kober, Thilo
    Schwarzer, Guido
    Herold, Michael
    Dreyling, Martin
    Hallek, Michael
    Engert, Andreas
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (09): : 706 - 714
  • [2] Rituximab maintenance improves overall survival of patients with follicular lymphoma Individual patient data meta-analysis
    Vidal, Liat
    Gafter-Gvili, Anat
    Salles, Gilles
    Bousseta, Sami
    Oberman, Bernice
    Rubin, Carmit
    van Oers, Marinus H. J.
    Fortpied, Catherine
    Ghielmini, Michele
    Pettengell, Ruth
    Witzens-Harig, Mathias
    Dreger, Peter
    Vitolo, Umberto
    da Silva, Maria Gomes
    Evangelista, Andrea
    Li, Hailun
    Freedman, Laurence
    Habermann, Thomas M.
    Shpilberg, Ofer
    EUROPEAN JOURNAL OF CANCER, 2017, 76 : 216 - 225
  • [3] Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma
    Vilmar, Adam
    Arboe, Bente
    Josefsson, Par
    Poulsen, Christian
    Christensen, Jacob Haaber
    Jorgensen, Judit
    Jensen, Paw
    Starklint, Jorn
    Pedersen, Per Troellund
    Pedersen, Michael
    Brown, Peter de Nully
    BLOOD, 2016, 128 (22)
  • [4] Rituximab-maintenance after a combined immunochemotherapy significantly improves response duration in patients with relapsed follicular and mantle cell lymphoma
    Hiddemann, W
    Dreyling, M
    Forstpointner, R
    Gramatzki, M
    Böck, H
    Haenel, M
    Seymour, J
    Unterhalt, M
    ANNALS OF ONCOLOGY, 2005, 16 : 169 - 169
  • [5] The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
    Luca Fischer
    Linmiao Jiang
    Joerg Thomas Bittenbring
    Kai Huebel
    Christian Schmidt
    Johannes Duell
    Bernd Metzner
    Juergen Krauter
    Bertram Glass
    Andreas Huettmann
    Kerstin Schaefer-Eckart
    Elisabeth Silkenstedt
    Wolfram Klapper
    Wolfgang Hiddemann
    Michael Unterhalt
    Martin Dreyling
    Eva Hoster
    Annals of Hematology, 2023, 102 : 2791 - 2801
  • [6] Rituximab Maintenance Therapy Improves Overall Survival in Patients with Relapsed Follicular Lymphoma
    Vidal, Liat
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04)
  • [7] Rituximab improves survival in mantle cell lymphoma
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (01) : 11 - 11
  • [8] The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis
    Fischer, Luca
    Jiang, Linmiao
    Bittenbring, Joerg Thomas
    Huebel, Kai
    Schmidt, Christian
    Duell, Johannes
    Metzner, Bernd
    Krauter, Juergen
    Glass, Bertram
    Huettmann, Andreas
    Schaefer-Eckart, Kerstin
    Silkenstedt, Elisabeth
    Klapper, Wolfram
    Hiddemann, Wolfgang
    Unterhalt, Michael
    Dreyling, Martin
    Hoster, Eva
    ANNALS OF HEMATOLOGY, 2023, 102 (10) : 2791 - 2801
  • [9] Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?
    Geisler, Christian
    Kolstad, Arne
    Laurell, Anna
    Raty, Riikka
    LEUKEMIA & LYMPHOMA, 2009, 50 (08) : 1249 - 1256
  • [10] Does combined immunochemotherapy with the monoclonal antibody Rituximab improve overall survival in the treatment of patients with indolent non-Hodgkin lymphoma? Preliminary results of a comprehensive meta-analysis.
    Schulz, H
    Skoetz, N
    Bohlius, J
    Trelle, S
    Kober, T
    Greb, A
    Engert, A
    BLOOD, 2005, 106 (11) : 106A - 107A
12345